Testing superiority and non-inferiority hypotheses in active controlled clinical trials

Biometrical Journal

Volumn 47, Issue 1, 2005, Pages 62-74

  Tsong, Yi ^a   Zhang, Juan ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Non inferiority test; Simultaneous test; Superiority test; Switching

Indexed keywords

ERROR ANALYSIS;

CLINICAL TRIAL; DESIGN AND ANALYSIS; NON-INFERIORITY; NON-INFERIORITY TEST; RATE ADJUSTMENT; SIMULTANEOUS TEST; SUPERIORITY TEST; SWITCHING; TESTING PROCEDURE; TYPE I ERROR RATE;

MEDICAL APPLICATIONS;

EID: 15244353300     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/bimj.200410089     Document Type: Article

References (19)

1. Dunnet, C. W. and Gent, M. (1977). Significance testing to establish equivalence between treatments, with special reference to data in the form of 2 × 2 tables. Biometrics 33, 593-602.
2. Durreleman, S. and Chaikin, P. (2003). The use of putative placebo in active control trials: two applications in a regulatory setting. Statistics In Medicine 22, 941-952.
3. Hasselblad V. and Kong, D. F. (2001). Statistical methods for comparison to placebo in active-control trials. Drug Information Journal 35, 435-449.
4. Hauschke, D., Kieser, M., Diletti, E., and Burke, M. (1999). Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Statistics In Medicine 18, 93-105.
5. Holmgren, E. B. (1999). Establishing equivalence by showing that a pre-specified percentage of the effect of the active control over placebo is maintained. Journal Biopharmaceutical Statistics 9, 651-659.
6. Hung, H.-M. J. and Wang, S.-J. (2004). Multiple testing of non-inferiority hypothesis in active controlled trials. J. of Biopharmaceutical Statistics 14, 327-335.
7. Hung, H.-M. J., Wang, S. J., Tsong, Y., Lawrence, J., and O'Neill, R. T. (2003). Some fundamental issues for non-inferiority testing in active controlled trials. Statistics In Medicine 22, 213-225.
8. Morikawa, T. and Yoshida, M. (1995). A useful testing strategy in phase III trials: Combined test of superiority and test of equivalence. Journal of Biopharmaceutical Statistics 5, 297-306.
9. Ng, T.-H. (2003). Issues of simultaneous tests for non-inferiority and superiority. J. of Biopharmaceutical Statistics 13, 629-639.
10. Pigeot, I., Schäfer, J., Röhmel, J., and Hauschke, D. (2003). Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. Statistics in Medicine 22, 883-899.
11. Rothman, M., Li, N., Chen, G., Chi, G., and Tsou, H. H. (2003). Design and analysis of non-inferiority mortality trials in oncology. Statistics In Medicine 22, 239-264.
12. Satterthwaite, F. E. (1946). An approximate distribution of estimates of variance components. Biometrics Bulletin 2, 110-114.
13. Tsong, Y., Wang, S.-J., and Hung, H.-M. J. (2003). Statistical issues in objectives, designs and analysis of non-inferiority test active controlled clinical trials. Journal of Biopharmaceutical Statistics 13, 29-41.
14. Tsong, Y., Zhang, J., and Wang, S.-J. (2004). Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products. Journal of Biopharmaceutical Statistics 14, 359-374.
15. Tsong, Y. and Chen, W. J. (2005). Statistical approaches for non-inferiority testing in trials with only test and active-control arms. Biometrical Journal 47, in press.
16. Wang, S.-J., Hung, H.-M. J., Tsong, Y., Cui, L., and Nuri, W. A. (2001). Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials. Statistics in Medicine 20, 1903-1912.
17. Wang, S.-J., Hung, H.-M. J., and Tsong, Y. (2002). Utility and pitfall of some statistical methods in active controlled clinical trials. Controlled Clinical Trials 23, 15-28.
18. Wang, S.-J. and Hung, H.-M. J. (2003). TACT method for non-inferiority testing in active controlled trials. Stat. In Medicine 22, 227-238.
19. Wang, S.-J. and Hung, H.-M. J. (2003). Assessing treatment efficacy in non-inferiority trials, Proceedings of Biopharmaceutical Section 3591-3596, 2003 ENAR Spring Meeting.